Why this chapter gets so much attention

If you spend any time around gyms, the peptides you will hear about most are the growth hormone ones. Chapter 11 of Peptides For Men focuses on them, mainly CJC-1295 and ipamorelin.

I want to use this part to explain the biology the book is describing, because it is genuinely interesting and because understanding it helps you judge the claims. I will not be repeating the book's dosing tables. Neither of these compounds is an approved medicine, and there is very little good human data on how they should be used.

The problem the book is describing

The book starts from a simple observation: after your late 20s, your natural growth hormone pulses get smaller. Recovery drags, soreness lingers, muscle is harder to build.

The decline itself is real and well documented. Growth hormone release falls with age, and it falls further with poor sleep, more body fat and less exercise. What is much less clear is whether pushing it back up in healthy middle-aged men produces meaningful benefits that outweigh the risks. That is the key question, and I will come back to it.

Two different buttons

What I find genuinely useful in this chapter is that it explains how the two main peptides work on different parts of the same system.

Your pituitary gland, at the base of the brain, releases growth hormone. It gets told when to do this by signals from the hypothalamus above it. Two of those signals matter here.

GHRH (growth hormone releasing hormone) is the main "go" signal. The book describes CJC-1295 as a synthetic version of GHRH. It taps the pituitary and tells it to release more of its own growth hormone.

Ghrelin is best known as the hunger hormone, but it also triggers growth hormone release through its own receptor. The book explains that ipamorelin works by activating these ghrelin receptors. It calls ipamorelin a "selective" secretagogue, meaning it triggers growth hormone release with less effect on other hormones like cortisol and prolactin than older compounds in the same family.

So one peptide presses the GHRH button, the other presses the ghrelin button. That is why they are often talked about together: two separate signals to the same gland.

Pulses versus a flat line

The book makes a point about rhythm that is worth understanding.

Your body does not release growth hormone at a steady rate. It comes in pulses, with the largest ones typically during deep sleep early in the night. The book argues that stimulating your own pituitary is different from injecting growth hormone directly, because you keep the pulsing pattern and the body's own feedback controls.

There is a real logic to this. When you inject growth hormone itself, the body's own production gets switched down. When you stimulate release instead, the pituitary is still doing the work, and the normal brakes on the system (like somatostatin, the hormone that stops release) are still in place.

That is also why the book recommends taking these at bedtime, on an empty stomach. Eating, especially carbohydrates, blunts growth hormone release. Timing things to line up with the natural night-time pulse is the idea.

The DAC detail

Part 2 mentioned that CJC-1295 comes in two forms, with and without DAC. This is where the difference matters.

Without DAC, the peptide lasts a short time and produces a short burst, closer to a natural pulse. With DAC, it binds to albumin in the blood and lasts about a week, producing a much longer, flatter elevation.

The book actually recommends the DAC version for muscle growth as "the biggest bang for your buck". But notice that this cuts against the book's own argument about preserving natural pulses. A week-long elevation is not a pulse. That is the kind of internal tension a careful reader should spot.

Where the book is careful

To its credit, the chapter includes some sensible warnings:

  • It says plainly there is no officially approved dosage for these peptides.
  • It lists possible side effects: headaches, flushing, dizziness, water retention.
  • It warns against combining with older compounds that raise cortisol or prolactin.
  • It recommends tracking fasting glucose and liver enzymes on longer use.
  • It says to consult a qualified provider and get bloodwork.

The glucose point is important. Growth hormone raises blood sugar. Anything that pushes growth hormone up over time can push insulin resistance up too, which is worth monitoring, especially for men already carrying extra weight.

IGF-1, the downstream signal

The book also introduces IGF-1, and this concept is worth knowing even if you never touch any of these compounds.

Growth hormone does much of its work indirectly. It travels to the liver, which then releases IGF-1 (insulin-like growth factor 1). The book's analogy is that growth hormone is the commander and IGF-1 is the special forces unit that carries out the orders: muscle repair, cell growth, fuel use.

That is why IGF-1 is the blood test used to check growth hormone status. If you ever want to know whether your growth hormone axis is actually low, IGF-1 is the number to ask about.

The honest bottom line

Here is where I land on this chapter.

The biology the book describes is real, and it explains it clearly. The two-button idea, the pulse argument and the IGF-1 relationship are genuinely useful to understand.

What the chapter does not provide is evidence that these peptides safely produce meaningful muscle gains in healthy men. There are no large, long-term human trials of CJC-1295 or ipamorelin for that purpose. The long list of benefits the book attaches to them (better cognition, immunity, skin, hair, nails) comes without any studies attached.

The reason that matters: IGF-1 is a growth signal. It tells cells to grow. That is useful for muscle, and it is also the reason people with a history of cancer are told to avoid growth-promoting treatments. The book does list a cancer history as a reason to hold off, which is correct.

If your recovery really has fallen off a cliff, the most useful first step the book suggests is also the cheapest one: check your IGF-1 and testosterone. Part 6 is about exactly that.

This series reviews a consumer book, not a clinical guideline. CJC-1295 and ipamorelin are not approved medicines. Nothing here is medical advice or a recommendation to use any substance. Speak to a qualified clinician before starting anything.